Browse studies
Find your next paid study
4 recruiting studies matching your filters
Phase 3
A Phase 3, Open-label, Randomized, Standard of Care-controlled, Parallel Study Arm Study to Demonstrate Efficacy and Safety of ARINA-1 in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) Progression in Participants With a Bilateral Lung Transplant
The goal of this Phase 3 clinical trial is to compare ARINA-1 (a nebulized immunomodulatory agent) plus Standard of Care vs Standard of Care alone. The main qu…
Pre-Bronchiolitis Obliterans Syndrome
Renovion, Inc.NCT05654922
Phase 2
An Open-Label, Phase 2 Study to Evaluate the Activity of Belumosudil in Subjects With New Onset and Incipient Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell Transplantation
The goal of this research study is to test the efficacy of a novel immunosuppressive agent, belumosudil, in allogeneic hematopoietic stem cell transplant (HSCT…
Bronchiolitis Obliterans SyndromeBronchiolitis ObliteransLung Diseases+1 more
Dana-Farber Cancer InstituteNCT05922761
The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)
This observational trial studies whether respiratory viruses are the cause of lung disease (bronchiolitis obliterans syndrome \[BOS\] or graft-versus-host dise…
Bronchiolitis Obliterans SyndromeHematopoietic and Lymphoid Cell Neoplasm
Fred Hutchinson Cancer CenterNCT05250037
Phase 2
A Randomized, Placebo-controlled Phase 2 Study to Demonstrate the Safety and Efficacy of the Addition of LAM-001 to Standard Immunosuppression Therapy for Chronic Lung Allograft Dysfunction (BOS).
The goal of this clinical trial is to learn about the safety and effectiveness of LAM-001 in patients who have developed bronchiolitis obliterans syndrome (BOS…
Bronchiolitis Obliterans SyndromeChronic Lung Allograft DysfunctionLung Transplantation
Steven Hays, MDNCT06018766